1-(4-fluorophenyl)-4-[2,4,6-trimethyl-3-[(1-pyridazin-3-ylpiperidin-4-yl)amino]benzoyl]piperazine-2-carboxamide
C30H36FN7O2 — CID 139473842
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-fluorophenyl)-4-[2,4,6-trimethyl-3-[(1-pyridazin-3-ylpiperidin-4-yl)amino]benzoyl]piperazine-2-carboxamide
1-(4-fluorophenyl)-4-[2,4,6-trimethyl-3-[(1-pyridazin-3-ylpiperidin-4-yl)amino]benzoyl]piperazine-2-carboxamide (PubChem CID 139473842) has the molecular formula C30H36FN7O2 and a molecular weight of 545.66 g/mol. Its IUPAC name is 1-(4-fluorophenyl)-4-[2,4,6-trimethyl-3-[(1-pyridazin-3-ylpiperidin-4-yl)amino]benzoyl]piperazine-2-carboxamide.
Molecular Properties
| Compound Name | 1-(4-fluorophenyl)-4-[2,4,6-trimethyl-3-[(1-pyridazin-3-ylpiperidin-4-yl)amino]benzoyl]piperazine-2-carboxamide |
|---|---|
| PubChem CID | 139473842 |
| Molecular Formula | C30H36FN7O2 |
| Molecular Weight | 545.66 g/mol |
| Exact Mass | 545.29 |
| IUPAC Name | 1-(4-fluorophenyl)-4-[2,4,6-trimethyl-3-[(1-pyridazin-3-ylpiperidin-4-yl)amino]benzoyl]piperazine-2-carboxamide |
| SMILES | Cc1cc(C)c(C(=O)N2CCN(c3ccc(F)cc3)C(C(N)=O)C2)c(C)c1NC1CCN(c2cccnn2)CC1 |
| InChI | InChI=1S/C30H36FN7O2/c1-19-17-20(2)28(34-23-10-13-36(14-11-23)26-5-4-12-33-35-26)21(3)27(19)30(40)37-15-16-38(25(18-37)29(32)39)24-8-6-22(31)7-9-24/h4-9,12,17,23,25,34H,10-11,13-16,18H2,1-3H3,(H2,32,39) |
| InChIKey | AOBVUFFECONFRA-UHFFFAOYSA-N |
| XLogP | 3.44 |
| TPSA | 107.69 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 545.66 |
| LogP ≤ 5 | 3.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139473842 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.